RTOG 0436: A Phase III Trial Evaluating the Addition of Cetuximab to Paclitaxel, Cisplatin and Radiation for Patients with Esophageal Cancer who are Treated without Surgery
Active, no longer recruiting
Phase of Trial: Phase III
Latest Information Update: 08 Apr 2015
At a glance
- Drugs Cetuximab (Primary) ; Cisplatin; Paclitaxel
- Indications Gastric cancer; Oesophageal cancer
- Focus Therapeutic Use
- 30 May 2014 Results presented at the 50th Annual Meeting of the American Society of Clinical Oncology.
- 18 Feb 2014 Primary endpoint 'Overall-survival-rate' has not been met.
- 18 Jan 2014 Results presented at the 2014 Gastrointestinal Cancers Symposium.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History